JO3552B1 - عملية لإنتاج محلول نورادرينالين ذو تركيز منخفض مستقر قابل للحقن - Google Patents

عملية لإنتاج محلول نورادرينالين ذو تركيز منخفض مستقر قابل للحقن

Info

Publication number
JO3552B1
JO3552B1 JOP/2015/0031A JOP20150031A JO3552B1 JO 3552 B1 JO3552 B1 JO 3552B1 JO P20150031 A JOP20150031 A JO P20150031A JO 3552 B1 JO3552 B1 JO 3552B1
Authority
JO
Jordan
Prior art keywords
noradrenaline
injectable solution
producing
solution
low concentration
Prior art date
Application number
JOP/2015/0031A
Other languages
English (en)
Inventor
Caronzolo Nicola
Donati Elisabetta
Mitidieri Augusto
Original Assignee
Sintetica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50693780&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JO3552(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sintetica S A filed Critical Sintetica S A
Application granted granted Critical
Publication of JO3552B1 publication Critical patent/JO3552B1/ar

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

في أحد الجوانب، يتعلق الاختراع الحالي إلى عملية لإنتاج محلول قابل للحقن ثابت مع محتوى منخفض من النورادرينالين، الذي يشتمل على تذويب النورادرينالين ويفضل أي مسوغ في مياه غير مؤكسدة أو مفرغ الغاز، وترشيح محلول النورادرينالين الناتج في محتوى غاز النيتروجين، وتوزيع المحلول في محتوى غاز النيتروجين والتعقيم ويفضل التسخين. كما يقدم الاختراع محلول قابل للحقن ثابت بمحتوى منخفض من النُورْأَدْرِنالين، حر بشكل كبير من العوامل مضاد الأكسدة والمواد الحافظة وكذلك استخدامها في المجالات الطبية والصيدلانية.
JOP/2015/0031A 2014-02-27 2015-02-12 عملية لإنتاج محلول نورادرينالين ذو تركيز منخفض مستقر قابل للحقن JO3552B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20140306 2014-02-27

Publications (1)

Publication Number Publication Date
JO3552B1 true JO3552B1 (ar) 2020-07-05

Family

ID=50693780

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2015/0031A JO3552B1 (ar) 2014-02-27 2015-02-12 عملية لإنتاج محلول نورادرينالين ذو تركيز منخفض مستقر قابل للحقن

Country Status (41)

Country Link
US (4) USRE49555E1 (ar)
EP (1) EP3110399B1 (ar)
JP (1) JP6635927B2 (ar)
KR (1) KR102306706B1 (ar)
CN (1) CN106061467B (ar)
AP (1) AP2016009467A0 (ar)
AR (1) AR101148A1 (ar)
AU (1) AU2015222150B2 (ar)
BR (1) BR112016019804B1 (ar)
CA (1) CA2940347C (ar)
CL (1) CL2016002073A1 (ar)
CR (1) CR20160420A (ar)
CY (1) CY1120125T1 (ar)
DK (1) DK3110399T3 (ar)
DO (1) DOP2016000210A (ar)
EA (1) EA031444B1 (ar)
EC (1) ECSP16065957A (ar)
ES (1) ES2663817T3 (ar)
HR (1) HRP20180541T1 (ar)
HU (1) HUE038738T2 (ar)
IL (1) IL247501B (ar)
JO (1) JO3552B1 (ar)
LT (1) LT3110399T (ar)
MA (1) MA39200A1 (ar)
MD (1) MD4628C1 (ar)
ME (1) ME03004B (ar)
MX (1) MX367148B (ar)
MY (1) MY179942A (ar)
NI (1) NI201600118A (ar)
PE (1) PE20161375A1 (ar)
PH (1) PH12016501703B1 (ar)
PL (1) PL3110399T3 (ar)
PT (1) PT3110399T (ar)
RS (1) RS57044B1 (ar)
SG (1) SG11201607094WA (ar)
SI (1) SI3110399T1 (ar)
SV (1) SV2016005265A (ar)
TW (1) TWI673065B (ar)
UA (1) UA118043C2 (ar)
UY (1) UY35988A (ar)
WO (1) WO2015128418A1 (ar)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY35988A (es) 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
ES2770731T3 (es) 2014-08-28 2020-07-02 Sun Pharmaceutical Ind Ltd Forma de dosificación parenteral de norepinefrina
CA3051467C (en) 2017-01-30 2022-11-29 Nevakar, Inc Norepinephrine compositions and methods therefor
CN109394683A (zh) * 2018-12-07 2019-03-01 远大医药(中国)有限公司 一种重酒石酸去甲肾上腺素注射液的制备方法
US10888534B2 (en) 2019-04-26 2021-01-12 InfoRLife SA Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags
EP4114336A1 (en) * 2020-03-06 2023-01-11 Baxter International Inc. Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation
US20230398070A1 (en) 2020-10-21 2023-12-14 Sintetica S.A. Stable, injectable noradrenaline solutions free of antioxidants
IL301878A (en) 2020-10-21 2023-06-01 Sintetica S A NORADRENALINE drip bags are ready to use, with a low sub-visible particle count
US11331266B1 (en) 2020-10-29 2022-05-17 Medefil, Inc. Antioxidant free, norepinephrine bitartrate injection in amber glass vials
US20220233473A1 (en) * 2021-01-28 2022-07-28 Cumberland Pharmaceuticals Inc. Injectable solution of norepinephrine
US20220257537A1 (en) 2021-02-15 2022-08-18 Sintetica S.A. Dilute ready to use large volume containers of phenylephrine

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
FR2832063B1 (fr) * 2001-11-15 2004-08-27 Aguettant Lab Procede de production de solutions stables de substances phenoliques et les solutions en resultant
EP1539170B1 (en) 2002-06-20 2014-08-13 Septodont Holding SAS Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
US20040005401A1 (en) 2002-07-05 2004-01-08 Robert Becker Method for applying a washcoat to suppport bodies
US7078876B2 (en) 2003-07-07 2006-07-18 Pentadyne Power Corporation Feedforward controller for synchronous reluctance machines
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
US7465489B2 (en) 2005-11-15 2008-12-16 Poly-Med, Inc. Inorganic-organic melted-extruded hybrid filaments and medical applications thereof
FR2894154B1 (fr) 2005-12-06 2008-03-14 Pharmatop Scr Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation.
EP2096433A1 (de) 2008-02-26 2009-09-02 Siemens Aktiengesellschaft Vorrichtung zur zerstörungsfreien Materialprüfung eines Prüfgegenstands mit Ultraschallwellen
US8419689B2 (en) 2008-09-30 2013-04-16 Covidien Lp Enclosing package for medical port and cover
JP2012528830A (ja) * 2009-06-04 2012-11-15 アルク アーゲー 少なくとも1つのアドレナリン作動性化合物を含む安定化された組成物
US8628805B2 (en) 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
FR2963237B1 (fr) 2010-07-28 2013-05-17 Aguettant Lab Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain
CN102525895B (zh) 2012-01-04 2013-11-06 上海禾丰制药有限公司 重酒石酸去甲肾上腺素注射液及其制剂工艺
UY35988A (es) 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
US20160005871A1 (en) 2014-07-04 2016-01-07 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device
CA3051467C (en) 2017-01-30 2022-11-29 Nevakar, Inc Norepinephrine compositions and methods therefor

Also Published As

Publication number Publication date
USRE49422E1 (en) 2023-02-21
MX2016011148A (es) 2016-12-09
UA118043C2 (uk) 2018-11-12
PL3110399T3 (pl) 2018-07-31
HUE038738T2 (hu) 2018-11-28
ES2663817T3 (es) 2018-04-17
DK3110399T3 (en) 2018-04-09
ME03004B (me) 2018-10-20
US10251848B2 (en) 2019-04-09
EP3110399A1 (en) 2017-01-04
BR112016019804B1 (pt) 2022-03-03
JP2017506632A (ja) 2017-03-09
CL2016002073A1 (es) 2017-02-10
EA031444B1 (ru) 2019-01-31
SI3110399T1 (en) 2018-05-31
US20170049720A1 (en) 2017-02-23
DOP2016000210A (es) 2016-11-30
PH12016501703A1 (en) 2016-12-19
SV2016005265A (es) 2017-01-18
UY35988A (es) 2015-09-30
MX367148B (es) 2019-08-07
WO2015128418A1 (en) 2015-09-03
RS57044B1 (sr) 2018-05-31
MD4628B1 (ro) 2019-05-31
KR102306706B1 (ko) 2021-09-30
CR20160420A (es) 2016-12-14
HRP20180541T1 (hr) 2018-05-04
MD20160103A2 (ro) 2017-01-31
EP3110399B1 (en) 2018-01-10
AU2015222150A1 (en) 2016-10-13
AP2016009467A0 (en) 2016-09-30
CA2940347A1 (en) 2015-09-03
AU2015222150B2 (en) 2019-12-05
TW201620499A (zh) 2016-06-16
AR101148A1 (es) 2016-11-30
CY1120125T1 (el) 2018-12-12
JP6635927B2 (ja) 2020-01-29
MY179942A (en) 2020-11-19
PH12016501703B1 (en) 2016-12-19
CN106061467B (zh) 2021-02-05
EA201691734A1 (ru) 2016-12-30
USRE49443E1 (en) 2023-03-07
PE20161375A1 (es) 2017-01-05
NI201600118A (es) 2016-10-03
BR112016019804A2 (ar) 2017-08-15
CN106061467A (zh) 2016-10-26
LT3110399T (lt) 2018-04-25
PT3110399T (pt) 2018-04-19
ECSP16065957A (es) 2017-01-31
MA39200A1 (fr) 2017-06-30
USRE49555E1 (en) 2023-06-20
TWI673065B (zh) 2019-10-01
IL247501A0 (en) 2016-11-30
SG11201607094WA (en) 2016-09-29
KR20160122264A (ko) 2016-10-21
MD4628C1 (ro) 2019-12-31
IL247501B (en) 2020-05-31
CA2940347C (en) 2021-04-27

Similar Documents

Publication Publication Date Title
PH12016501703B1 (en) Process for producing a stable low concentration, injectable solution of noradrenaline
TN2017000452A1 (en) Compositions of obeticholic acid and methods of use
MX2017004838A (es) Composiciones de interleucina-15 y usos de estas.
MX2017001281A (es) Material anisotropico biocompuesto, implantes medicos que lo comprenden y metodos para el tratamiento del mismo.
MX2023000796A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
BR112016022394A2 (pt) Composição farmaceuticamente aceitável, composição na forma de uma solução injetável farmaceuticamente aceitável, uso da composição, e, método para a preparação da composição injetável farmaceuticamente aceitável
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
SA517390475B1 (ar) نظام أكياس متعددة وطريقة لتحضير مكونات الدم
AR100618A1 (es) Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido
MX2018006226A (es) Agente estimulador del receptor 1b de 5-hidroxitriptamina para mejorar el potencial de injerto in vivo.
TW201713686A (en) Methods for preparing modified von Willebrand factor
MX2017006899A (es) Sintesis de polioles polimericos en polioles insaturados, polioles polimericos y su uso.
MX2016010229A (es) Conjugados del factor vii.
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
MD4763B1 (ro) Compoziţie farmaceutică
MX2018014135A (es) Tratamiento del dolor.
CL2012003402A1 (es) Composición líquida natural antioxidante concentrada preparada sólo con componentes de hierbas y arbustos producidos bajo técnicas orgánicas, endulzada con stevia y el método de preparación de dicha composición.
UA103987C2 (ru) Способ терновской т.а. лечения варикозной болезни детей
UA92917U (uk) Спосіб профілактики ферумдефіцитної анемії поросят
TH1501007678A (th) สารละลายไฮโดรเจนเพอร์ออกไซด์ที่ใช้สำหรับฆ่าเชื้อแบคทีเรียและวิธีการผลิตนั้น รวมทั้งวิธีการฆ่าเชื้อแบคทีเรียโดยใช้สารดัวกล่าว
IN2013MU01252A (ar)